Vision Care Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Vision Care Market Trends and Insights

Rising Refractive Errors and Myopia Burden

The vision care market is experiencing growth due to the increasing prevalence of refractive errors, particularly myopia, among children and adolescents. A 2025 review highlighted that global myopia prevalence in this group reached 35.81% in 2023 and is projected to rise to 39.80% by 2050, affecting nearly 740 million individuals.^{[1]World Health Organization, “Eye Care, Vision Impairment and Blindness, Refractive Errors,” World Health Organization, who.int} This trend is driving the market beyond single-vision correction toward products designed to slow myopia progression, enhancing value per patient. The FDA's approval of Essilor Stellest in 2025, the first spectacle lens in the U.S. to slow pediatric myopia progression, has expanded the addressable market. Additionally, China's focus on school-level myopia screenings continues to drive demand, particularly in East Asia, where prevalence rates are already high.

Aging-Driven Demand for Presbyopia and Cataract Care

The aging population is fueling demand for presbyopia correction, cataract surgeries, and improved postoperative vision, contributing to the vision care market's growth. Cataracts remain the leading cause of global blindness, with over 20 million surgeries performed annually, including 4.3 million in Europe and 3.8 million in the U.S.^{[2]Jinghong Liang et al., “Global Prevalence, Trend and Projection of Myopia in Children and Adolescents From 1990 to 2050, A Comprehensive Systematic Review and Meta-Analysis,” British Journal of Ophthalmology, bjo.bmj.com} The market is seeing a shift toward premium intraocular lenses, which reduce spectacle dependence and generate out-of-pocket payments even in reimbursed systems. Alcon's launch of Clareon PanOptix Pro in 2025 and Bausch + Lomb's reported premium IOL growth of over 20% in Q4 2025 highlight the increasing preference for advanced visual outcomes. With global blindness and visual impairments projected to rise from 338.3 million in 2020 to 535 million by 2050, the aging trend will continue to support market expansion^{.[3]Stephen O'Brart, “The Global Burden of Cataract and Cataract Blindness,” Eye, doi.org}

Digital-Eye-Strain Demand for Premium Lenses and Coatings

Rising screen time among working-age adults is driving demand for premium spectacle lenses, coatings, and contact lenses that offer comfort, dryness reduction, and extended wear. Employers, insurers, and consumers increasingly view digital strain as a recurring vision care need, supporting repeat purchases and product upgrades. Comfort-related features justify premium pricing, especially as daily screen exposure remains high. This trend is fostering a more profitable product mix in both spectacles and contact lenses, establishing digital strain as a sustained growth driver in the vision care market.

Omnichannel Optical Retail and E-Commerce Expansion

Channel dynamics are becoming a key growth driver in the vision care market, particularly for products with regular prescriptions and predictable reorder cycles. While e-commerce is reshaping revenue capture after initial prescriptions, physical stores remain essential for complex prescriptions and surgical needs. EssilorLuxottica's Direct-to-Consumer segment reported EUR 14.89 billion (USD 21.45 billion) in revenue for FY2025, with 10.3% growth, showcasing the shift toward integrated models. These models combine manufacturing, retail data, fulfillment, and clinical relationships, enhancing convenience and driving premium product adoption. The market is becoming more accessible for online repeat buyers while maintaining the importance of in-person care.

Premium-Product Affordability and Reimbursement Gaps

The vision care market faces a significant challenge as clinical needs far exceed the affordability of premium corrective or therapeutic services for many patients. The World Health Organization's SPECS 2030 framework aims to address this gap by increasing coverage for refractive error services by 2030. Annual productivity losses from uncorrected myopia are estimated at USD 244 billion globally, with many in low-income regions still lacking basic eyeglasses. This economic barrier impacts the adoption of fast-growing product segments like myopia-control lenses and premium surgical implants, which often rely on out-of-pocket spending. Without expanded reimbursements or affordable alternatives, affordability will continue to limit growth in high-potential regions.

Counterfeit Products and Online Compliance Friction

The vision care market also struggles with compliance issues in online channels, where unregulated products frequently reach consumers. Counterfeit or improperly dispensed contact lenses pose risks of corneal complications, undermining trust in the broader market. Legitimate manufacturers face increased costs for authentication, distributor monitoring, and prescription verification, which can reduce profit margins from digital sales. While e-commerce remains a key growth driver, it requires stricter operational controls to address these challenges effectively.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Spectacle Lenses Keep Scale While Contact Lenses Lead Growth

Spectacle lenses accounted for 52.45% of the vision care market in 2025, maintaining their position as the leading product type due to their widespread prescription and ease of adoption across patient groups. This reflects the foundational role of spectacles in addressing refractive errors in both developed and developing regions. Premium designs, advanced coatings, and myopia-control features are driving revenue growth, even as unit sales grow at a slower pace. 

Contact lenses are the fastest-growing segment, with an 8.20% CAGR projected through 2031. Growth is driven by premium daily disposables, improved comfort, and their increasing role in myopia management, narrowing the value gap with premium spectacles. Intraocular lenses are also gaining traction due to rising cataract surgeries and a shift toward trifocal and extended-depth-of-focus designs, enhancing postoperative visual range. 

By Application: Therapeutic Care Expands Beyond Traditional Correction

Corrective vision care held 44.6% of the market share in 2025, reflecting its role as the core revenue driver for optical dispensing and routine prescription updates. Most patient journeys in vision care begin with refraction and standard correction, ensuring the segment's continued relevance. However, providers are broadening the scope of visits to include recurring therapy, diagnostics, and follow-up care, moving beyond single corrective sales.

Therapeutic and disease management is the fastest-growing segment, with a 9.10% CAGR projected through 2031. Bausch + Lomb’s dry eye portfolio exceeded USD 1.1 billion in FY2025 revenue, with MIEBO contributing USD 316 million, highlighting the growing therapeutic market. Preventive and protective vision care is expanding as awareness of UV exposure, dry eye, and workplace strain increases. Cosmetic and lifestyle vision care remains a smaller niche, influenced more by fashion trends, safety compliance, and urban spending than disease prevalence.

By Age Group: Adult Demand Dominates While Pediatric Care Gains Speed

Adults accounted for 52.89% of the vision care market in 2025, driven by purchasing power, daily digital exposure, and growing interest in premium lenses. This group forms the core of the market, often seeking both routine corrections and performance-oriented upgrades like progressive or digital-use lenses. Adults also represent the primary customer base for optical retailers and employer-linked benefit programs, ensuring stable replacement cycles and funding innovation in pediatric progression control and advanced surgical solutions.

The pediatric segment is the fastest-growing age category, with a 7.98% CAGR forecast through 2031. Growth is linked to rising childhood myopia and the introduction of approved interventions that go beyond observation. Refraction disorders among children and adolescents increased from 21.49 million cases in 1990 to 24.45 million in 2023, with projections reaching 24.21 million by 2030. Geriatric demand is also strengthening, with refraction disorder cases among older adults more than doubling from 29.26 million in 1990 to a projected 79.71 million by 2030, supporting cataract care and premium IOL adoption.

By Distribution Channel: Physical Stores Hold Scale While Digital Sales Accelerate

Optical retail stores and chains held 38.75% of the vision care market in 2025, maintaining their position as the leading distribution channel. In-person care remains critical for prescription capture, fitting, and dispensing, especially for first-time buyers, multifocal users, and patients with complex needs. Store networks provide major brands with pricing control, clinical referral links, and insights into replacement cycles, ensuring continued investment in retail despite the growth of digital channels.

E-commerce platforms are the fastest-growing distribution channel, with an 11.15% CAGR projected through 2031. The digital channel is well-suited for repeat purchases like contact lenses and replacement eyewear, where prescription data allows for standardized fulfillment. Hospitals and ophthalmology clinics remain essential for surgical products, with EssilorLuxottica’s 2025 acquisition of Optegra adding over 70 eye hospitals across five European countries, integrating clinical and retail pathways. Pharmacies and drugstores are also gaining relevance, with Bausch + Lomb reporting 19% growth in its OTC dry eye portfolio over the year leading to late 2025.

Geography Analysis

In 2025, North America accounted for 44.67% of the global vision care market, driven by high per-capita spending, extensive private coverage, and strong innovation cycles. The U.S. leads regional demand due to a significant myopic population and rapid commercialization of new products. The FDA's approval of Essilor Stellest in September 2025 and the expanded age criteria for EVO ICL treatments in February 2026 have broadened access to premium care. While Canada and Mexico add depth, the U.S. remains the primary driver of pricing power. Cost inflation poses a challenge, with Alcon projecting a net tariff impact of USD 125 million to USD 175 million in its 2026 guidance.

Europe remains a mature vision care market, supported by aging populations, established clinical networks, and steady adoption of premium surgical products. Growth varies across the region due to differences in reimbursement policies and consumer spending between Western and Eastern Europe. Germany's optical market, for example, reported only 1% to 2% revenue growth in early 2026, constrained by cautious consumer spending. EssilorLuxottica's acquisition of Optegra highlights the growing integration of ophthalmology services with optical dispensing in the region.

Asia-Pacific is projected to achieve the fastest growth in the vision care market, with a 10.15% CAGR through 2031. The region benefits from high demand density, with myopia prevalence reaching 80% to 90% among school-leavers in parts of East Asia, supported by systematic public screening programs. East Asia leans toward high prevalence and premium product adoption, while China, Japan, India, and Southeast Asia offer growth potential due to uneven access. South America and the Middle East and Africa remain smaller contributors, with progress tied to urbanization and improved access rather than premium product penetration.